Zdrowie i gospodarka · 17/10/2018

FDA Releases Draft Guidance on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Labeling and Advertisements

The Food and Drug Administration (FDA) has released a draft guidance for industry that provides recommendations for presenting quantitative efficacy and risk information in direct-to-consumer promotional labeling and advertisements for prescription and over-the-counter animal drugs, with the goal of making the language and presentation more consumer-friendly.